Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126412282 | 12641228 | 2 | F | 20160912 | 20160810 | 20160916 | PER | US-PFIZER INC-2016356657 | PFIZER | 0.00 | A | F | Y | 52.16000 | KG | 20160916 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126412282 | 12641228 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | 20235 | 300 | MG | CAPSULE, HARD | TID | ||||||
| 126412282 | 12641228 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | 20235 | CAPSULE, HARD | |||||||||||
| 126412282 | 12641228 | 3 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.25 MG AS NEEDED BY MOUTH PILL | 0 | .25 | MG | ||||||||
| 126412282 | 12641228 | 4 | C | DICLOFENAC | DICLOFENAC | 1 | Topical | 1 PERCENT TOPICAL GEL | 0 | 1 | PCT | GEL | |||||||
| 126412282 | 12641228 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG PILL BY MOUTH ONCE DAILY | 0 | 5 | MG | QD | |||||||
| 126412282 | 12641228 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10MG PILL ONCE DAILY BY MOUTH | 0 | 10 | MG | QD | |||||||
| 126412282 | 12641228 | 7 | C | BETAMETHASONE DIPROPIONATE. | BETAMETHASONE DIPROPIONATE | 1 | 0.5 PERCENT CREAM | 0 | .5 | PCT | CREAM | ||||||||
| 126412282 | 12641228 | 8 | C | CARISOPRODOL. | CARISOPRODOL | 1 | Oral | PRESCRIBED 350 MG PILL 3 TIMES A DAY AS NEEDED | 0 | ||||||||||
| 126412282 | 12641228 | 9 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG PILL ONCE DAILY BY MOUTH | 0 | 40 | MG | QD | |||||||
| 126412282 | 12641228 | 10 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | WILL TAKE 3 X PER DAY WHEN HAS SPELLS | 0 | 20 | MG | CAPSULE | ||||||||
| 126412282 | 12641228 | 11 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | CAPSULE | QD | ||||||
| 126412282 | 12641228 | 12 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | EVERY 6 HOURS AS NEEDED [HYDROCODONE 5MG]/[PARACETAMOL 325 MG] | 0 | TABLET | ||||||||||
| 126412282 | 12641228 | 13 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | 5 MG PILL 2 OR 3 TIMES PER DAY AS NEEDED | 0 | 5 | MG | |||||||||
| 126412282 | 12641228 | 14 | C | TEMAZEPAM. | TEMAZEPAM | 1 | Oral | 30 MG CAPUSLE NIGHTLY BY MOUTH | 0 | 30 | MG | CAPSULE | |||||||
| 126412282 | 12641228 | 15 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG XR TIME RELEASE CAPSULE ONCE DAILY AND BY MOUTH | 0 | 150 | MG | CAPSULE | QD | ||||||
| 126412282 | 12641228 | 16 | C | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 126412282 | 12641228 | 17 | C | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126412282 | 12641228 | 1 | Muscle spasms |
| 126412282 | 12641228 | 2 | Pain |
| 126412282 | 12641228 | 4 | Neuralgia |
| 126412282 | 12641228 | 5 | Blood pressure abnormal |
| 126412282 | 12641228 | 6 | Blood cholesterol abnormal |
| 126412282 | 12641228 | 7 | Muscle disorder |
| 126412282 | 12641228 | 8 | Muscle spasms |
| 126412282 | 12641228 | 9 | Blood cholesterol abnormal |
| 126412282 | 12641228 | 10 | Irritable bowel syndrome |
| 126412282 | 12641228 | 11 | Gastrooesophageal reflux disease |
| 126412282 | 12641228 | 12 | Pain |
| 126412282 | 12641228 | 13 | Nausea |
| 126412282 | 12641228 | 14 | Insomnia |
| 126412282 | 12641228 | 15 | Depression |
| 126412282 | 12641228 | 16 | Sinus disorder |
| 126412282 | 12641228 | 17 | Hypersensitivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126412282 | 12641228 | Condition aggravated | |
| 126412282 | 12641228 | Drug ineffective for unapproved indication | |
| 126412282 | 12641228 | Feeling abnormal | |
| 126412282 | 12641228 | Musculoskeletal discomfort |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126412282 | 12641228 | 3 | 1998 | 0 | ||
| 126412282 | 12641228 | 5 | 1998 | 0 | ||
| 126412282 | 12641228 | 8 | 1996 | 0 | ||
| 126412282 | 12641228 | 12 | 1990 | 0 | ||
| 126412282 | 12641228 | 14 | 1998 | 0 | ||
| 126412282 | 12641228 | 15 | 1998 | 0 |